| Frequencies of graft cell subsets, (%), mean ± SD |  | Doses of graft cell subsets infused, 106 cells/kg of body weight, median (min–max) |  | ||
---|---|---|---|---|---|---|
G-BM (n = 49) | G-PBSC (n = 52) | P | G-BM (n = 49) | G-PBSC (n = 52) | P | |
CD3+ | 60 ± 10 | 68.0 ± 14.0 | 0.007 | 69.6(22–156) | 285.8(68–467) | <0.001 |
CD3+CD4+ | 29 ± 8.7 | 35.0 ± 10.7 | 0.065 | 33(10–56) | 139.3(45–257) | <0.001 |
CD4+CD45RA+ | 9.5 ± 5.7 | 13.1 ± 8.1 | 0.220 | 11(3–30) | 51.3(16–121) | <0.001 |
CD4+CD45RO+ | 13.8 ± 7.7 | 16.2 ± 8.0 | 0.647 | 16(5–39) | 63.6(16–150) | <0.001 |
CD3+CD8+ | 26.6 ± 7.4 | 27.9 ± 9.2 | 0.297 | 30(25–59) | 111.8(28–265) | <0.001 |
CD8+CD45RA+ | 19.6 ± 6.6 | 20.5 ± 7.6 | 0.625 | 22(11–60) | 79.0(20–189) | <0.001 |
CD4+/CD8+ | 1.04 ± 0.5 | 1.12 ± 0.5 | 0.967 |  |  |  |
CD19+ | 12.3 ± 5.0 | 12.7 ± 6.0 | 0.659 | 14(5–42) | 48.5(12–90) | <0.001 |
CD3−CD56+ | 10.0 ± 7.0 | 7.0 ± 8.9 | 0.144 | 12(6–38) | 27.9(3–76) | <0.010 |
Treg | 3.1 ± 3.2 | 2.3 ± 2.0 | 0.192 | 3.0(1.5–6.7) | 8.6(3.6–12.6) | <0.010 |
MDSCs | 0.66 ± 0.23 | 0.40 ± 0.19 | <0.01 | 3.9(1.4–7.3) | 3.5(1.7–6.0) | 0.045 |